NCT06657430View on ClinicalTrials.gov

A Study on the Preference of Risperidone Dosage Forms

RecruitingOBSERVATIONAL

Enrollment

1,000

Participants

Timeline

Start Date

September 19, 2024

Primary Completion Date

February 28, 2025

Study Completion Date

February 28, 2025

Conditions

SchizophreniaBipolar Affective DisorderAutism Spectrum DisorderConduct DisorderMental Retardation

Trial Locations (1)

200030

RECRUITING

Shanghai Mental Health Center, Shanghai

All Listed Sponsors

lead

Shanghai Mental Health Center

OTHER